Xvivo Perfusion AB (publ)
World Rank (Jan-05-2024)
8,543
Market Cap (Jan-05-2024)
1.007 Billion USD
World Rank (Jul-30-2023)
9,414
Market Cap (Jul-30-2023)
0.876 Billion USD
World Rank (Dec-25-2022)
12,339
Market Cap (Dec-25-2022)
0.505 Billion USD
World Rank (Jan-07-2022)
10,439
Market Cap (Jan-07-2022)
0.83 Billion USD
Annual Revenue in USD
24 Million USD
Annual Net Income in USD
1 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
Xvivo Perfusion AB (publ) is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. The company annual revenue is 179.8 million SEK and total assets are 1,150 million SEK as on 2020. The headquarters is in Sweden.
Company Website